Critical Reviews in Therapeutic Drug Carrier Systems

Papers
(The TQCC of Critical Reviews in Therapeutic Drug Carrier Systems is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Polymeric Nanoparticles Revolutionizing Brain Cancer Therapy: A Comprehensive Review of Strategies and Advances27
Insight on the Rise and Raise of Drug Delivery with Special Emphasis on Five Classes of Therapeutics22
Microneedle-Mediated Delivery for Targeted Cancer Therapy: A Comprehensive Review20
Recent Advances in Teriparatide Delivery by-virtue-of Novel Drug Delivery Approaches for the Management of Osteoporosis19
17
17
15
Cyclodextrin-Based Supramolecular Ternary Complexes: Emerging Role of Ternary Agents on Drug Solubility, Stability, and Bioavailability13
12
Long-Acting Drug Delivery Technologies for Meloxicam as a Pain Medicine12
Crafting Immunological Response Using Particulate Vaccines11
11
Recent Progress in Self-Emulsifying Drug Delivery Systems: A Systematic Patent Review (2011-2020)11
11
Immunotherapy in Cervical Cancer: An Evolutionary Paradigm in Women's Reproductive Health10
10
Exploration of 3D Printing of Anti-Infective Urinary Catheters: Materials and Approaches to Combat Catheter-Associated Urinary Tract Infections (CAUTIs) - A Review10
10
Immunomodulation and Anticancer Immunity: Reviewing the Potential of Probiotics and Their Delivery with Macromolecular Carriers9
Grafting of Natural Polymers and Gums for Drug Delivery Applications: A Perspective Review8
Oral Dispersible Films from Product Development to End-User Acceptability: A Review8
Exploring the Therapeutic Potential of Cyclosporine for Ophthalmic Indications by Novel Carrier Systems8
Advanced Technologies of Drug Delivery to the Posterior Eye Segment Targeting Angiogenesis and Ocular Cancer8
Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges8
Implementation of Quality by Design in the Formulation and Development of Nanocarrier-Based Drug Delivery Systems7
Reverse engineering and advanced characterization techniques for cost-effective and bioequivalent generic formulation development7
Enhancing Microemulsion-Based Therapeutic Drug Delivery: Exploring Surfactants, Co-Surfactants, and Quality-by-Design Strategies within Pseudoternary Phase Diagrams6
Theranostic Approach for the Management of Osteoporosis6
6
Current Review on Nanophytomedicines in the Treatment of Oral Cancer: Recent Trends and Treatment Prospects6
0.13671088218689